Investigate the inhibitor development rate of Human cl rhFVIII in previously untreated patients with severe Hemophilia A.
Severe Hemophilia A
Severe Hemophilia A (FVIII:C <1%)
No previous treatment with FVIII concentrates or other blood products containing FVIII
Diagnosis with a coagulation disorder other than Hemophilia A
Severe liver or kidney disease
Concomitant treatment with any systemic immunosuppressive drug
Human cl rhFVIII
January 19, 2021
Primary Contact Information
For more information on this trial, visit clinicaltrials.gov.
For more information and to contact the study team: